Dr Arnaud Bayle is a medical oncologist and health economist working at Gustave Roussy Cancer Center (Villejuif, France). He is also Assistant Professor at Paris Saclay University.

Dr Bayle trained as a medical oncologist (MD) at Paris Descartes University and obtained the Silver medal from Paris Medical School in 2020. In parallel, Dr Bayle graduated in 2015 from ESSEC Business School with a Master of Science (MSc) in Management and finished first in his year of the ESSEC Chair of Health Systems (class of 2013). 

Dr Bayle has a specific interest in Public Health and holds a PhD in Health Economics from Paris Saclay University in the field of biomarkers and precision medicine. 

In addition to his clinical experience at Assistance Publique des Hôpitaux de Paris (AP-HP) and at Gustave Roussy in the Drug Development Department (DITEP), Dr Bayle has been working for the World Health Organization (WHO) at the office to the European Union in Brussels. He also worked for the French Ministry of Health at the Directorate of Social Security (DSS) in charge of healthcare system financing and at the Inspection Générale des Affaires Sociales (IGAS), which is the French Government audit, evaluation and inspection office for health, social security, social cohesion, employment and labour policies and organisations. He is currently a Permanent member of the Commission on Diagnostic, Prognostic and Predictive Health Technologies Assessment (CEDiag) at the French National Authority for Health (HAS).

Dr Bayle is a member of ESMO Public Policy Committee and ESMO Cancer Medicine Committee.